Organon And Co 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Organon And Co 's ROA in the second quarter of 2026?
Organon And Co recorded a cumulative net loss of $-5 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -0.04%.

However, within the Healthcare sector 212 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2500, from total ROA ranking in the first quarter of 2026 at 2969.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-2.39 %	-1.22 %	-1.79 %	6.27 %	11.07 %
Y / Y Net Income Change	-25.52 %	67.82 %	-	-55.43 %	-25.64 %
Net Income (TTM) in million	-5	32	-27	501	700
Return On Assets (TTM)	-0.04 %	0.24 %	-0.2 %	3.76 %	5.33 %
OGN's Total Ranking	# 2500	# 2969	# 1410	# 1119	# 1053
Total Assets (TTM) in million	13,178	12,996	12,867	13,552	13,500
Seq. Total Assets Change	1.4 %	1 %	-5.05 %	0.39 %	2.61 %
Seq. Net Income Change	-26.03 %	-	-	10.34 %	66.67 %

OGN's 5 Years Annual ROA >> Back to OGN Management Effectiveness >> Compare OGN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 72
Sector	# 213
Overall	# 2533

Return On Assets Statistics
High	Average	Low
12.7 %	6.93 %	-0.2 %
(Dec 31 2021)

Financial Statements
Organon And Co 's Assets	$ 13,178 million	OGN's Balance sheet
Organon And Co 's Income	$ 108 million	Quarterly OGN's Income Statement
OGN's Income by Division		See OGN's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-1.79 %	8.65 %	10.07 %	2.57 %	-
Total Assets in million	12,867	13,101	12,058	10,955	10,681
Y / Y Net Income Change	-78.36 %	-15.54 %	11.56 %	-32.12 %	-
Net Income in million	187	864	1,023	917	1,351
Annual Return On Assets	1.45 %	6.59 %	8.48 %	8.37 %	12.65 %

OGN's 5 Years Annual ROA >> Back to OGN Management Effectiveness >> Compare OGN ROA to its Competitors

Comment on OGN's ROA in the fiscal year ending 2025

In the fiscal year 2025 Organon And Co 's ROA decreased compared to previous year to 1.45 %, due to deterioration of net income -78.36 % to $187.00 million, from $864.00 million a year ago, as OGN's assets were $12,867.00 million.

More Return On Assets Ratios
OGN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OGN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OGN's Competitors
Subscribers only: Roa for Organon And Co 's Suppliers
Subscribers only: Return On Assets for OGN's Customers

You may also want to know
OGN's Roi	OGN's Inventory Turnover Ratio	OGN's Growth Rates	OGN's Dividend Comparisons
	OGN's Profitability Ratios	OGN's Asset Turnover Ratio	OGN's Dividend Growth
OGN's Roe	OGN's Valuation Ratios	OGN's Financial Strength Ratios	OGN's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:25:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.